ArticleNeuro-oncology2026

Beyond dose escalation in glioblastoma: Lessons learned from INTRAGO-II and the case for targeting tumor biology.

Julian Philipp Layer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.